Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

In vivo quantification and perturbation of Myc-Max interactions and the impact on oncogenic potential

12 Oct 2014

Abstract excerpt

// Philipp Raffeiner 1 , Ruth Röck 1 , Andrea Schraffl 1 , Markus Hartl 1 , Jonathan R. Hart 2 , Kim D. Janda 3 , Peter K. Vogt 2 , Eduard Stefan 1 and Klaus Bister 1 1 Institute of Biochemistry and Center for Molecular Biosciences, University of Innsbruck, Innsbruck, Austria 2 Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, CA 3 Department of Chemistry, The Scripps...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer-related Molecular Pathways
Share to Protein Kinase Regulation and GTPase Signaling
Share to Ubiquitin and proteasome pathways

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 25326649
DOI: 10.18632/oncotarget.2588

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 23 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

In vivo quantification and perturbation of Myc-Max interactions and the impact on oncogenic potentialPMID 25326649Read ↗

A selective high affinity MYC-binding compound inhibits MYC:MAX interaction and MYC-dependent tumor cell proliferationSemantic proximity Read ↗

A novel inhibitor L755507 efficiently blocks c-Myc–MAX heterodimerization and induces apoptosis in cancer cellsSemantic proximity Read ↗

MAX and MYC: A Heritable BreakupSemantic proximity Read ↗

Targeting MYC Proteins for Tumor TherapySemantic proximity Read ↗

Drosophila Myc is oncogenic in mammalian cells and plays a role in the diminutive phenotype.Semantic proximity Read ↗

Small-molecule inhibitors of c-Myc transcriptional factor suppress proliferation and induce apoptosis of promyelocytic leukemia cell via cell cycle arrestSemantic proximity Read ↗

Direct inhibition of c-Myc-Max heterodimers by celastrol and celastrol-inspired triterpenoidsSemantic proximity Read ↗

Gene-regulatory properties of Myc helix-loop-helix/leucine zipper mutants: Max-dependent DNA binding and transcriptional activation in yeast correlates with transforming capacity.Semantic proximity Read ↗

Viral mutations enhance the Max binding properties of the vMyc b-HLH-LZ domain.Semantic proximity Read ↗

Strategies to target the cancer driver MYC in tumor cellsSemantic proximity Read ↗

Targeting of the MYCN Protein with Small Molecule c-MYC InhibitorsSemantic proximity Read ↗

MYCMI-7: A Small MYC-Binding Compound that Inhibits MYC: MAX Interaction and Tumor Growth in a MYC-Dependent MannerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.